ABEONA THERAPEUTICS INC. (20)
Browse by Contract Category
Contracts
-
Letter Agreement, dated October 26, 2020, between Abeona Therapeutics Inc. and Michael Amoroso
(Filed With SEC on October 30, 2020)
-
Form of Indemnification Agreement
(Filed With SEC on October 16, 2020)
-
Description of Capital Stock of Abeona Therapeutics Inc
(Filed With SEC on March 16, 2020)
-
First Amendment to License Agreement, dated November 1, 2019, between the Company and REGENXBIO Inc
(Filed With SEC on November 12, 2019)
-
Amendment No. 3, dated April 14, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh
(Filed With SEC on August 10, 2020)
-
Offer Letter between Abeona Therapeutics Inc. and Edward Carr, dated June 18, 2020
(Filed With SEC on June 23, 2020)
-
Amendment No. 2, dated March 31, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh
(Filed With SEC on May 6, 2020)
-
Letter Agreement, dated March 13, 2020, between the Company and Christine Berni Silverstein
(Filed With SEC on May 6, 2020)
-
Amendment No. 1, dated March 6, 2020, to Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh
(Filed With SEC on May 6, 2020)
-
Letter Agreement, dated January 2, 2020, between the Company and Steven H. Rouhandeh
(Filed With SEC on May 6, 2020)
-
Offer Letter, dated April 15, 2020, between Abeona Therapeutics Inc. and Brian J.G. Pereira, M.D
(Filed With SEC on April 21, 2020)
-
Letter Agreement regarding Certain Purchaser Rights, dated December 20, 2019, among the Company, Biomedical Value Fund, L.P., Biomedical Offshore Value Fund, Ltd., and GEF-SMA, L.P
(Filed With SEC on December 23, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on December 23, 2019)
-
Underwriting Agreement, dated December 20, 2019, among the Company, Jefferies LLC and SVB Leerink LLC
(Filed With SEC on December 23, 2019)
-
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Edward Carr, dated November 9, 2018
(Filed With SEC on November 12, 2019)
-
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Christine Berni Silverstein, dated January 8, 2019
(Filed With SEC on November 12, 2019)
-
Letter Agreement, dated September 12, 2019, amending Offer Letter between the Company and Joo Siffert, M.D., dated February 11, 2019
(Filed With SEC on November 12, 2019)
-
License Agreement, dated November 4, 2018, between the Company and REGENXBIO Inc
(Filed With SEC on March 18, 2019)
-
Offer Letter, dated February 11, 2019, by and between Abeona Therapeutics Inc. and Joo Siffert, M.D
(Filed With SEC on February 13, 2019)
-
Offer Letter, dated January 8, 2019, by and between Abeona Therapeutics Inc. and Christine Berni Silverstein
(Filed With SEC on January 10, 2019)